Saturday 17 October 2026
Export MLAB’s income statement to Excel — free account
Mesa Laboratories, Inc.
MLAB Technology Scientific & Technical Instruments
Mesa Laboratories, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $249.1 million, up 3.38% from fiscal 2025. In the quarter to June 2026, revenue grew 1.00%, EPS fell 42.5%, free cash flow grew 1,503.7% and total debt rose 70.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
122.48
5.26
−4.12%
Follow MLAB
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
40.50 | 0.00 | 117.38 | 471.02 | 392.74 | 688.86 | 1,027.82 | 0.00 | 0.00 | 71.89 |
Piotroski F-Score |
4 | 4 | 7 | 4 | 7 | 4 | 7 | 4 | 6 | 7 |
P/S ratio |
4.82 | 5.58 | 8.52 | 8.07 | 9.04 | 7.21 | 4.24 | 2.79 | 2.67 | 1.96 |
Altman Z-Score |
5.26 | 6.51 | 13.27 | 3.90 | 4.72 | 3.11 | 2.72 | (0.75) | 1.31 | 1.45 |
P/FCF ratio |
79.21 | 22.32 | 27.88 | 37.23 | 34.53 | 38.18 | 39.67 | 14.51 | 15.11 | 12.32 |
Altman Z″-Score (non-manufacturers) |
4.16 | 3.64 | 4.93 | 3.48 | 5.67 | 2.42 | 2.69 | (3.97) | (1.48) | 0.37 |
P/Operating CF |
42.86 | 55.68 | 85.63 | 107.52 | 89.60 | 142.81 | 74.27 | 46.82 | 50.79 | 34.92 |
Beneish M-Score |
(2.64) | (3.32) | (3.20) | (2.36) | (2.74) | (1.83) | (2.68) | (6.03) | (2.79) | (2.80) |
P/B ratio |
4.61 | 5.40 | 7.89 | 4.32 | 2.98 | 3.37 | 2.36 | 4.15 | 4.02 | 2.62 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 67 |
Price to Tangible BV |
0.00 | 0.00 | 75.01 | 0.00 | 9.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.36 | 6.02 | 8.64 | 8.58 | 8.17 | 8.14 | 4.94 | 3.70 | 2.89 | 2.46 |
EV/EBITDA |
20.05 | 22.73 | 37.16 | 34.32 | 36.99 | 97.25 | 29.71 | 22.67 | 16.55 | 14.65 |
EV/Operating CF |
29.03 | 22.51 | 29.17 | 37.41 | 29.52 | 38.25 | 38.70 | 18.12 | 14.88 | 14.29 |
EV/FCF |
88.13 | 24.07 | 28.28 | 39.58 | 31.19 | 43.12 | 46.20 | 19.23 | 16.37 | 15.46 |
Quick Ratio |
1.22 | 1.14 | 0.96 | 3.94 | 8.83 | 1.88 | 1.74 | 1.52 | 0.42 | 1.15 |
Current Ratio |
2.16 | 1.85 | 1.42 | 4.72 | 9.32 | 2.59 | 2.74 | 2.47 | 0.63 | 1.72 |
Net Debt/EBITDA |
1.96 | 1.60 | 0.52 | 2.04 | (3.96) | 11.14 | 4.20 | 5.49 | 1.27 | 2.98 |
Debt/Assets |
31.91% | 28.19% | 14.50% | 34.56% | 24.39% | 31.26% | 28.12% | 49.62% | 18.61% | 35.41% |
Debt/Equity |
0.56 | 0.47 | 0.20 | 0.64 | 0.36 | 0.56 | 0.47 | 1.52 | 0.50 | 0.81 |
Asset Turnover |
0.56 | 0.57 | 0.64 | 0.42 | 0.27 | 0.28 | 0.32 | 0.39 | 0.55 | 0.58 |
Operating CF/Net income |
1.55 | (8.68) | 4.08 | 15.18 | 11.32 | 20.96 | 30.09 | (0.17) | (23.71) | 6.38 |
Capex/Depreciation |
(1.33) | (0.07) | 0.07 | (0.07) | (0.12) | (0.41) | (0.14) | (0.01) | (0.17) | (0.14) |
Interest Coverage |
— | 1.18 | 5.59 | 1.44 | 1.54 | 1.21 | 0.70 | (47.76) | 1.38 | 1.73 |
| 12.26% | (3.00%) | 7.10% | 1.07% | 1.05% | 0.47% | 0.24% | (94.36%) | (1.29%) | 3.88% | |
| 6.73% | (1.76%) | 4.66% | 0.63% | 0.65% | 0.29% | 0.14% | (45.87%) | (0.45%) | 1.56% | |
ROIC |
6.95% | 0.97% | 4.94% | 1.77% | 2.67% | 0.52% | 0.38% | (50.18%) | 4.79% | 3.72% |
Return on Tangible Assets |
24.73% | (7.74%) | 23.25% | 1.50% | 1.12% | 1.78% | 0.90% | (262.63%) | 6.82% | 8.95% |
Average Days of Receivables |
55.80 | 54.28 | 44.29 | 65.54 | 64.82 | 81.63 | 70.89 | 65.94 | 63.57 | 64.61 |
Research and Development Expense of Revenue |
4.44% | 3.68% | 3.40% | 5.40% | 7.76% | 8.55% | 9.35% | 8.93% | 8.10% | 8.15% |
Selling, General and Administrative Expense of Revenue |
34.99% | 36.47% | 38.35% | 43.41% | 47.98% | 48.08% | 50.16% | 51.57% | 47.73% | 47.95% |
Intangible Assets out of Total Assets |
0.64 | 0.66 | 0.64 | 0.64 | 0.45 | 0.77 | 0.76 | 0.66 | 0.64 | 0.63 |
Share Based Compensation of Revenue |
1.51% | 1.74% | 4.08% | 4.69% | 6.92% | 6.18% | 5.72% | 5.52% | 5.45% | 7.17% |
Graham Net Nets |
(0.08) | (0.06) | (0.01) | (0.07) | 0.09 | (0.14) | (0.16) | (0.32) | (0.27) | (0.28) |
Graham Number |
42.58 | 0.00 | 35.67 | 23.79 | 33.75 | 25.08 | 16.82 | 0.00 | 0.00 | 30.57 |
Earnings Yield |
2.47% | (0.54%) | 0.85% | 0.21% | 0.25% | 0.15% | 0.10% | (42.09%) | (0.30%) | 1.39% |
Free Cash Flow Yield |
1.26% | 4.48% | 3.59% | 2.69% | 2.90% | 2.62% | 2.52% | 6.89% | 6.62% | 8.12% |
Revenue per Share |
25.46 | 25.51 | 26.87 | 28.02 | 26.92 | 35.37 | 41.17 | 40.14 | 44.45 | 45.18 |
Operating CF per Share |
4.70 | 6.82 | 7.96 | 6.43 | 7.45 | 7.53 | 5.26 | 8.19 | 8.63 | 7.77 |
Capex per Share |
(3.15) | (0.44) | 0.25 | (0.35) | (0.40) | (0.85) | (0.85) | (0.48) | (0.83) | (0.59) |
Free Cash Flow per Share |
1.55 | 6.38 | 8.21 | 6.07 | 7.05 | 6.68 | 4.41 | 7.72 | 7.80 | 7.18 |
Cash per Share |
1.58 | 1.45 | 2.65 | 19.38 | 53.04 | 9.47 | 6.18 | 5.24 | 5.04 | 4.88 |
Shareholders Equity per Share |
26.59 | 26.36 | 28.99 | 52.38 | 81.65 | 75.56 | 73.95 | 26.99 | 29.48 | 33.78 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
26.59 | 26.36 | 28.99 | 52.38 | 81.65 | 75.56 | 73.95 | 26.99 | 29.48 | 33.78 |
Free Cash Flow |
5.70 | 24.05 | 31.51 | 25.51 | 35.08 | 34.79 | 23.44 | 41.57 | 42.31 | 39.58 |
Working Capital |
19.22 | 14.70 | 9.96 | 96.78 | 271.17 | 76.26 | 75.62 | 65.04 | (61.28) | 44.37 |
Capital Expenditures |
(11.60) | (1.67) | 0.96 | (1.48) | (1.99) | (4.43) | (4.54) | (2.57) | (4.50) | (3.25) |
Net Current Asset Value |
(38.13) | (32.75) | (11.83) | (66.30) | 108.50 | (189.25) | (149.38) | (192.05) | (170.83) | (135.23) |
EV/EBIT |
30.79 | 265.24 | 91.11 | 127.42 | 88.55 | 319.06 | 326.20 | 0.00 | 42.64 | 33.07 |
Capex to Sales |
0.12 | 0.02 | (0.01) | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
Price to Operating Income |
27.67 | 245.92 | 89.84 | 119.85 | 98.03 | 282.53 | 280.04 | 0.00 | 39.38 | 26.34 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.34 | 0.99 | 0.64 | 0.97 | 0.78 | 0.37 | 1.18 | 9.68 | 0.80 | 0.76 |
Cash ROIC |
3.60% | 15.92% | 21.85% | 5.76% | 4.29% | 5.24% | 3.83% | 10.51% | 15.80% | 10.85% |
Accounts Receivable Turnover |
6.32 | 6.72 | 7.69 | 7.00 | 5.96 | 5.67 | 5.23 | 5.30 | 5.95 | 5.79 |
Accounts Payable Turnover |
16.20 | 18.28 | 16.00 | 16.60 | 11.91 | 12.17 | 12.17 | 13.62 | 15.29 | 17.02 |
Inventory Turnover |
2.90 | 3.60 | 5.28 | 4.98 | 3.69 | 4.21 | 2.88 | 2.46 | 3.11 | 3.51 |
Average Days of Payables |
19.57 | 20.90 | 25.05 | 23.77 | 34.79 | 38.31 | 26.22 | 26.59 | 23.28 | 19.80 |
Days of Inventory on Hand |
125.26 | 81.04 | 58.55 | 99.26 | 86.95 | 119.36 | 148.08 | 143.80 | 102.75 | 105.94 |
Average Receivables |
14.82 | 14.31 | 13.41 | 16.82 | 22.46 | 32.51 | 41.89 | 40.80 | 40.51 | 43.03 |
Average Payables |
2.50 | 2.27 | 2.64 | 3.15 | 3.94 | 6.19 | 7.02 | 6.09 | 5.89 | 5.34 |
Average Inventory |
13.95 | 11.55 | 8.00 | 10.50 | 12.70 | 17.89 | 29.62 | 33.66 | 29.02 | 25.87 |
Average Assets |
166.24 | 167.92 | 160.43 | 282.94 | 505.29 | 654.42 | 684.60 | 554.31 | 440.07 | 430.55 |
Average Common Equity |
91.25 | 98.59 | 105.34 | 165.66 | 313.12 | 400.01 | 393.64 | 269.44 | 152.61 | 173.04 |
Columns are period end dates